{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:59:43Z","timestamp":1786409983061,"version":"build-2736575974"},"reference-count":38,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2019,11,15]],"date-time":"2019-11-15T00:00:00Z","timestamp":1573776000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"UK Department for International Development","award":["DFID; GB-1-202037"],"award-info":[{"award-number":["DFID; GB-1-202037"]}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MC_UU_12023\/23"],"award-info":[{"award-number":["MC_UU_12023\/23"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MC-UU-12023\/26"],"award-info":[{"award-number":["MC-UU-12023\/26"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>We describe the decentralisation of antiretroviral therapy (ART) alongside Option B+ roll-out in public healthcare facilities in the Lablite project in Uganda. Lessons learned will inform programmes now implementing universal test and treat (UTT).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Routine data were retrospectively extracted from ART registers between October 2012 and March 2015 for all adults and children initiating ART at two primary care facilities (spokes) and their corresponding district hospitals (hubs) in northern and central Uganda. We describe ART initiation over time and retention and use of Cox models to explore risk factors for attrition due to mortality and loss to follow-up. Results from tracing of patients lost to follow-up were used to correct retention estimates.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Of 2100 ART initiations, 1125 were in the north, including 944 (84%) at the hub and 181 (16%) at the spokes; children comprised 95 (10%) initiations at the hubs and 14 (8%) at the spokes. Corresponding numbers were 642 (66%) at the hub and 333 (34%) at the spokes in the central region (77 [12%] and 22 [7%], respectively, in children). Children &amp;lt;3\u00a0y of age comprised the minority of initiations in children at all sites. Twenty-three percent of adult ART initiations at the north hub were Option B+ compared with 45% at the spokes (25% and 65%, respectively, in the central region). Proportions retained in care in the north hub at 6 and 12\u00a0mo were 92% (95% CI 90 to 93) and 89% (895% CI 7 to 91), respectively. Corresponding corrected estimates in the north spokes were 87% (95% CI 78 to 93) and 82% (95% CI 72 to 89), respectively. In the central hub, corrected estimates were 84% (95% CI 80 to 87) and 78% (95% CI 74 to 82), and were 89% (95% CI 77.9 to 95.1) and 83% (95% CI 64.1 to 92.9) at the spokes, respectively. Among adults newly initiating ART, being older was independently associated with a lower risk of attrition (adjusted hazard ratio [aHR] 0.93 per 5\u00a0y [95% CI 0.88 to 0.97]). Other independent risk factors included initiating with a tenofovir-based regimen vs zidovudine (aHR 0.60 [95% CI 0.46 to 0.77]), year of ART initiation (2013 aHR 1.55 [95% CI 1.21 to 1.97], \u22652014 aHR 1.41 [95% CI 1.06 to 1.87]) vs 2012, hub vs spoke (aHR 0.35 [95% CI 0.29 to 0.43]) and central vs north (aHR 2.28 [95% CI 1.86 to 2.81]). Independently, patient type was associated with retention.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>After ART decentralisation, people living with human immunodeficiency virus (HIV) were willing to initiate ART in rural primary care facilities. Retention on ART was variable across facilities and attrition was higher among some groups, including younger adults and women initiating ART during pregnancy\/breastfeeding. Interventions to support these groups are required to optimise benefits of expanded access to HIV services under UTT.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/inthealth\/ihz090","type":"journal-article","created":{"date-parts":[[2019,8,28]],"date-time":"2019-08-28T18:46:02Z","timestamp":1567017962000},"page":"429-443","source":"Crossref","is-referenced-by-count":7,"title":["Lessons for test and treat in an antiretroviral programme after decentralisation in Uganda: a retrospective analysis of outcomes in public healthcare facilities within the Lablite project"],"prefix":"10.1093","volume":"12","author":[{"given":"S","family":"Kiwuwa-Muyingo","sequence":"first","affiliation":[{"name":"Medical Research Council\/Uganda Virus Research Institute and London School of Hygiene and Tropical Medicine , Uganda Research Unit, PO Box 49, Entebbe,","place":["Uganda"]},{"name":"African Population and Health Research Center , P.O. Box 10787-00100, Kitisuru, Nairobi,","place":["Kenya"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Abongomera","sequence":"additional","affiliation":[{"name":"Joint Clinical Research Centre , PO Box 10005, Kampala,","place":["Uganda"]},{"name":"University of Zurich , Epidemiology, Biostatistics and Prevention Institute, CH 8001, Zurich,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I","family":"Mambule","sequence":"additional","affiliation":[{"name":"Infectious Diseases Institute , Makerere University, PO Box 22418, Kampala,","place":["Uganda"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Senjovu","sequence":"additional","affiliation":[{"name":"Infectious Diseases Institute , Makerere University, PO Box 22418, Kampala,","place":["Uganda"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Katabira","sequence":"additional","affiliation":[{"name":"Infectious Diseases Institute , Makerere University, PO Box 22418, Kampala,","place":["Uganda"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Kityo","sequence":"additional","affiliation":[{"name":"Joint Clinical Research Centre , PO Box 10005, Kampala,","place":["Uganda"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D M","family":"Gibb","sequence":"additional","affiliation":[{"name":"Medical Research Council , Clinical Trials Unit at University College London, London WC1V\u00a06LH,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Ford","sequence":"additional","affiliation":[{"name":"Medical Research Council , Clinical Trials Unit at University College London, London WC1V\u00a06LH,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Seeley","sequence":"additional","affiliation":[{"name":"Medical Research Council\/Uganda Virus Research Institute and London School of Hygiene and Tropical Medicine , Uganda Research Unit, PO Box 49, Entebbe,","place":["Uganda"]},{"name":"Global Health and Development Department , London School of Hygiene & Tropical Medicine, London, WC1E\u00a07HT,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,11,15]]},"reference":[{"key":"2025010606412444200_ref1","volume-title":"Prevention gap report","author":"Joint United Nations Programme on HIV\/AIDS","year":"2016"},{"key":"2025010606412444200_ref2","volume-title":"UNAIDS data 2018","author":"Joint United Nations Programme on HIV\/AIDS","year":"2018"},{"issue":"9845","key":"2025010606412444200_ref3","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0140-6736(12)60730-2","article-title":"Task shifting of antiretroviral treatment from doctors to primary-care nurses in South Africa (STRETCH): a pragmatic, parallel, cluster-randomised trial","volume":"380","author":"Fairall","year":"2012","journal-title":"Lancet."},{"issue":"1","key":"2025010606412444200_ref4","doi-asserted-by":"crossref","DOI":"10.3402\/gha.v6i0.22274","article-title":"Decentralised paediatric HIV care in Ethiopia: a comparison between outcomes of patients managed in health centres and in a hospital clinic","volume":"6","author":"Hagstromer","year":"2013","journal-title":"Glob Health Action."},{"issue":"Suppl 1","key":"2025010606412444200_ref5","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1365-3156.2010.02503.x","article-title":"Outcome assessment of decentralization of antiretroviral therapy provision in a rural district of Malawi using an integrated primary care model","volume":"15","author":"Chan","year":"2010","journal-title":"Trop Med Int Health."},{"issue":"5","key":"2025010606412444200_ref6","doi-asserted-by":"crossref","first-page":"e124","DOI":"10.1097\/QAI.0b013e3182869558","article-title":"Decentralization of pediatric HIV care and treatment in five sub-Saharan African countries","volume":"62","author":"Fayorsey","year":"2013","journal-title":"J Acquir Immune Defic Syndr."},{"issue":"1","key":"2025010606412444200_ref7","doi-asserted-by":"crossref","DOI":"10.7448\/IAS.19.1.20662","article-title":"Factors associated with loss to follow-up among women in Option B+ PMTCT programme in northeast Ethiopia: a retrospective cohort study","volume":"19","author":"Mitiku","year":"2016","journal-title":"J Int AIDS Soc."},{"issue":"5","key":"2025010606412444200_ref8","doi-asserted-by":"crossref","first-page":"e77","DOI":"10.1097\/QAI.0000000000000517","article-title":"Implementation and operational research: the impact of Option B+ on the antenatal PMTCT cascade in Lilongwe, Malawi","volume":"68","author":"Kim","year":"2015","journal-title":"J Acquir Immune Defic Syndr."},{"issue":"5","key":"2025010606412444200_ref9","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1097\/QAI.0000000000001267","article-title":"Implementation of antiretroviral therapy for life in pregnant\/breastfeeding HIV+ women (Option B+) alongside rollout and changing guidelines for ART initiation in rural Zimbabwe: the Lablite project experience","volume":"74","author":"Ford","year":"2017","journal-title":"J Acquir Immune Defic Syndr."},{"key":"2025010606412444200_ref10","volume-title":"Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV","author":"World Health Organization"},{"key":"2025010606412444200_ref11","article-title":"The Uganda HIV and AIDS country progress report July 2015\u2013June 2016","author":"Uganda AIDS Commission"},{"issue":"Suppl 2","key":"2025010606412444200_ref12","doi-asserted-by":"crossref","first-page":"S111","DOI":"10.1097\/QAI.0000000000001366","article-title":"Improving retention in care among pregnant women and mothers living with HIV: lessons from INSPIRE and implications for future WHO guidance and monitoring","volume":"75","author":"Rollins","year":"2017","journal-title":"J Acquir Immune Defic Syndr."},{"issue":"4","key":"2025010606412444200_ref13","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/s11904-010-0061-5","article-title":"Retention in care among HIV-infected patients in resource-limited settings: emerging insights and new directions","volume":"7","author":"Geng","year":"2010","journal-title":"Curr HIV\/AIDS Rep."},{"issue":"12","key":"2025010606412444200_ref14","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1111\/tmi.12386","article-title":"Retention and risk factors for attrition among adults in antiretroviral treatment programmes in Tanzania, Uganda and Zambia","volume":"19","author":"Koole","year":"2014","journal-title":"Trop Med Int Health."},{"key":"2025010606412444200_ref15","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s12879-016-1392-7","article-title":"Predictors of dropout from care among HIV-infected patients initiating antiretroviral therapy at a public sector HIV treatment clinic in sub-Saharan Africa","volume":"16","author":"Asiimwe","year":"2016","journal-title":"BMC Infect Dis."},{"issue":"12","key":"2025010606412444200_ref16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0083524","article-title":"Comparison of methods for correction of mortality estimates for loss to follow-up after ART initiation: a case of the Infectious Diseases Institute, Uganda","volume":"8","author":"Kiragga","year":"2013","journal-title":"PLoS One."},{"issue":"5","key":"2025010606412444200_ref17","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/QAI.0000000000001616","article-title":"Retention in HIV care during pregnancy and the postpartum period in the Option B+ era: systematic review and meta-analysis of studies in Africa","volume":"77","author":"Knettel","year":"2018","journal-title":"J Acquir Immune Defic Syndr."},{"issue":"2","key":"2025010606412444200_ref18","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1093\/inthealth\/ihx006","article-title":"Impact of decentralisation of antiretroviral therapy services on HIV testing and care at a population level in Agago District in rural northern Uganda: results from the Lablite population surveys","volume":"9","author":"Abongomera","year":"2017","journal-title":"Int Health."},{"key":"2025010606412444200_ref19","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1186\/s12913-015-1194-4","article-title":"Population level usage of health services, and HIV testing and care, prior to decentralization of antiretroviral therapy in Agago District in rural northern Uganda","volume":"15","author":"Abongomera","year":"2015","journal-title":"BMC Health Serv Res."},{"issue":"5","key":"2025010606412444200_ref20","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1001\/jama.300.5.506","article-title":"Sampling-based approach to determining outcomes of patients lost to follow-up in antiretroviral therapy scale-up programs in Africa","volume":"300","author":"Geng","year":"2008","journal-title":"JAMA."},{"issue":"1","key":"2025010606412444200_ref21","doi-asserted-by":"crossref","DOI":"10.7189\/jogh.09.010424","article-title":"Changes in patterns of retention in HIV care and antiretroviral treatment in Tanzania between 2008 and 2016: an analysis of routinely collected national programme data","volume":"9","author":"Mee","year":"2019","journal-title":"J Glob Health."},{"issue":"1","key":"2025010606412444200_ref22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0085310","article-title":"Women\u2019s preferences regarding infant or maternal antiretroviral prophylaxis for prevention of mother-to-child transmission of HIV during breastfeeding and their views on Option B+ in Dar es Salaam, Tanzania","volume":"9","author":"Ngarina","year":"2014","journal-title":"PLoS One."},{"issue":"1","key":"2025010606412444200_ref23","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1186\/s12889-016-3767-5","article-title":"Lessons learned from the PMTCT program in Swaziland: challenges with accepting lifelong ART for pregnant and lactating women \u2013 a qualitative study","volume":"16","author":"Katirayi","year":"2016","journal-title":"BMC Public Health."},{"issue":"2","key":"2025010606412444200_ref24","doi-asserted-by":"crossref","first-page":"e25084","DOI":"10.1002\/jia2.25084","article-title":"Retention and mortality on antiretroviral therapy in sub-Saharan Africa: collaborative analyses of HIV treatment programmes","volume":"21","author":"Haas","year":"2018","journal-title":"J Int AIDS Soc."},{"issue":"2","key":"2025010606412444200_ref25","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1177\/0956462417721658","article-title":"Assessing Option B+ retention and infant follow-up in Lilongwe, Malawi","volume":"29","author":"Hauser","year":"2018","journal-title":"Int J STD AIDS."},{"issue":"7","key":"2025010606412444200_ref26","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1093\/cid\/civ1004","article-title":"Retention in care and patient-reported reasons for undocumented transfer or stopping care among HIV-infected patients on antiretroviral therapy in eastern Africa: application of a sampling-based approach","volume":"62","author":"Geng","year":"2016","journal-title":"Clin Infect Dis."},{"issue":"8","key":"2025010606412444200_ref27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0159994","article-title":"Facility-level factors influencing retention of patients in HIV care in East Africa","volume":"11","author":"Rachlis","year":"2016","journal-title":"PLoS One."},{"key":"2025010606412444200_ref28","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/1472-6963-11-81","article-title":"Outcomes of antiretroviral treatment program in Ethiopia: retention of patients in care is a major challenge and varies across health facilities","volume":"11","author":"Assefa","year":"2011","journal-title":"BMC Health Serv Res."},{"key":"2025010606412444200_ref29","article-title":"Outcomes of antiretroviral treatment programmes in rural Lesotho: health centres and hospitals compared","volume":"16(1)","author":"Labhardt","year":"2013","journal-title":"J Int AIDS Soc."},{"issue":"4","key":"2025010606412444200_ref30","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/tmi.12843","article-title":"Outcomes of HIV-positive patients lost to follow-up in African treatment programmes","volume":"22","author":"Zurcher","year":"2017","journal-title":"Trop Med Int Health."},{"issue":"9","key":"2025010606412444200_ref31","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1093\/cid\/cit490","article-title":"High retention in care among HIV-infected patients entering care with CD4 levels &gt;350 cells\/\u03bcL under routine program conditions in Uganda","volume":"57","author":"Namusobya","year":"2013","journal-title":"Clin Infect Dis."},{"issue":"5","key":"2025010606412444200_ref32","doi-asserted-by":"crossref","first-page":"e160","DOI":"10.1097\/QAI.0000000000000772","article-title":"Implementation and operational research: early tracing of children lost to follow-up from antiretroviral treatment: true outcomes and future risks","volume":"70","author":"Ardura-Garcia","year":"2015","journal-title":"J Acquir Immune Defic Syndr."},{"issue":"2","key":"2025010606412444200_ref33","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/QAI.0b013e31827b70bf","article-title":"Outcomes of antiretroviral therapy in children in Asia and Africa: a comparative analysis of the IeDEA pediatric multiregional collaboration","volume":"62","author":"Leroy","year":"2013","journal-title":"J Acquir Immune Defic Syndr."},{"issue":"12","key":"2025010606412444200_ref34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0142722","article-title":"Outcomes in a cohort of patients started on antiretroviral treatment and followed up for a decade in an urban clinic in Uganda","volume":"10","author":"Castelnuovo","year":"2015","journal-title":"PLoS One."},{"key":"2025010606412444200_ref35","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1186\/s12879-019-3934-2","article-title":"Retention in care and virological failure among adult HIV+ patients on second-line ART in Rwanda: a national representative study","volume":"19","author":"Nsanzimana","year":"2019","journal-title":"BMC Infect Dis."},{"issue":"9","key":"2025010606412444200_ref36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0108615","article-title":"Retention and risk factors for attrition in a large public health ART program in Myanmar: a retrospective cohort analysis","volume":"9","author":"Thida","year":"2014","journal-title":"PLoS One."},{"issue":"Suppl 2","key":"2025010606412444200_ref37","doi-asserted-by":"crossref","first-page":"S190","DOI":"10.1097\/QAI.0000000000001341","article-title":"Impact of point-of-care CD4 testing on retention in care among HIV-positive pregnant and breastfeeding women in the context of Option B+ in Zimbabwe: a cluster randomized controlled trial","volume":"75","author":"Joseph","year":"2017","journal-title":"J Acquir Immune Defic Syndr."},{"issue":"Suppl 2","key":"2025010606412444200_ref38","doi-asserted-by":"crossref","first-page":"S139","DOI":"10.1097\/QAI.0000000000000326","article-title":"Does provision of point-of-care CD4 technology and early knowledge of CD4 levels affect early initiation and retention on antiretroviral treatment in HIV-positive pregnant women in the context of Option B+ for PMTCT?","volume":"67","author":"Mangwiro","year":"2014","journal-title":"J Acquir Immune Defic Syndr."}],"container-title":["International Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/inthealth\/article-pdf\/12\/5\/429\/61332066\/inthealth_12_5_429.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/inthealth\/article-pdf\/12\/5\/429\/61332066\/inthealth_12_5_429.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T06:41:47Z","timestamp":1736145707000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/inthealth\/article\/12\/5\/429\/5626305"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,15]]},"references-count":38,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2019,11,15]]},"published-print":{"date-parts":[[2020,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/inthealth\/ihz090","relation":{},"ISSN":["1876-3413","1876-3405"],"issn-type":[{"value":"1876-3413","type":"print"},{"value":"1876-3405","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,9]]},"published":{"date-parts":[[2019,11,15]]}}}